Zevalin blev desuden undersøgt hos i alt 306 patienter med non- Hodgkins lymfom, hos hvem behandlingen ikke længere virkede eller hos hvem sygdommen var vendt tilbage efter tidligere behandling.
Zevalin has also been studied in a total of 306 patients with non-Hodgkin’ s lymphoma who were not responding to other treatments or whose disease had come back after previous treatment.